Literature DB >> 22073826

Microbiological profile of peritoneal dialysis peritonitis and predictors of hospitalization.

Jose Antonio Quintanar Lartundo1, Rosa Palomar, Agustin Dominguez-Diez, Carlos Salas, Jorge Ruiz-Criado, Emilo Rodrigo, Angel Luis Martinez De Francisco, Manolo Arias.   

Abstract

Peritonitis, the major complication of peritoneal dialysis (PD), is associated with high morbidity and mortality. It is a major cause of hospitalization and transfer to hemodialysis. In the present study, we aimed to identify predictors of hospitalization in PD-related peritonitis and to examine its microbiology profile over time in our unit to determine the best therapeutic approach. We studied all peritonitis episodes that occurred in a 6-year period (January 1, 2004, to December 31, 2009), evaluating whether adequate treatment could be delivered on an outpatient basis. During the study period, 411 patients were on PD, and 229 peritonitis episodes were recorded in 91 patients. Peritonitis were treated according to unit protocol. The average hospital stay was 11.6 +/- 6.6 days. We observed an increase of Streptococcus (to 19.4% from 7.7%) and a stabilization of coagulase-negative Staphylococcus, S. epidermidis, and S. aureus (from 9.5%, 22.6%, and 3.2% to 7.7%, 30.8%, and 3.8% respectively) peritonitis episodes. The main risk factors for hospitalization were fungal infection, poor 72-hour outcome, inability to perform self-care, and age greater than 80 years. We observed a decline in the incidence of peritonitis, and despite changes in its microbiology profile, no loss of sensitivity to antibiotics used was observed.

Entities:  

Mesh:

Year:  2011        PMID: 22073826

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  6 in total

Review 1.  Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis.

Authors:  Pasqual Barretti; João Vitor Pereira Doles; Douglas Gonçalves Pinotti; Regina Paolucci El Dib
Journal:  World J Nephrol       Date:  2015-05-06

2.  Peritonitis incidence was correlated with duration of peritoneal dialysis rather than leptin or neutrophil to lymphocyte (n/l) ratio in peritoneal dialysis patients.

Authors:  Yusuf Bilen; Erdem Cankaya; Nurhan Bilen; Mustafa Keles; Fuat Erdem; Abdullah Uyanik; M Hamidullah Uyanik
Journal:  Eurasian J Med       Date:  2014-08-26

3.  Effects of a Statewide Protocol for the Management of Peritoneal Dialysis-Related Peritonitis on Microbial Profiles and Antimicrobial Susceptibilities: A Retrospective Five-Year Review.

Authors:  Amanda L McGuire; Christine F Carson; Timothy J J Inglis; Aron Chakera
Journal:  Perit Dial Int       Date:  2015-07-07       Impact factor: 1.756

Review 4.  Efficacy of antibiotic therapy for peritoneal dialysis-associated peritonitis: a proportional meta-analysis.

Authors:  Pasqual Barretti; João Vitor Pereira Doles; Douglas Gonçalves Pinotti; Regina El Dib
Journal:  BMC Infect Dis       Date:  2014-08-18       Impact factor: 3.090

5.  Dialysate White Blood Cell Change after Initial Antibiotic Treatment Represented the Patterns of Response in Peritoneal Dialysis-Related Peritonitis.

Authors:  Pichaya Tantiyavarong; Opas Traitanon; Piyatida Chuengsaman; Jayanton Patumanond; Adis Tasanarong
Journal:  Int J Nephrol       Date:  2016-08-30

6.  Syndecan-1 (CD138) deficiency increases Staphylococcus aureus infection but has no effect on pathology in a mouse model of peritoneal dialysis.

Authors:  Paulina M Kowalewska; Uyen T Nguyen; Lori L Burrows; Alison E Fox-Robichaud
Journal:  J Biomed Sci       Date:  2016-02-01       Impact factor: 8.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.